EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2

Dongbum Kim, Jinsoo Kim, Minyoung Kim, Heedo Park, Sangkyu Park, Sony Maharjan, Kyeongbin Baek, Bo Min Kang, Suyeon Kim, Man-Seong Park, Younghee Lee, Hyung-Joo Kwon

Frontiers in Cellular and Infection Microbiology · 2023

DOI: 10.3389/fcimb.2023.1280686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2023. Verfasst von Dongbum Kim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Science, College of Medicine, Hallym University, Chuncheon, Republic of Korea. Hauptthemen laut MEDLINE: SARS-CoV-2, Spike Glycoprotein, Coronavirus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Health Industry Development Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The spectrum of SARS-CoV-2 mutations have increased over time, resulting in the emergence of several variants of concern. Persistent infection is assumed to be involved in the evolution of the variants. Calu-3 human lung cancer cells persistently grow without apoptosis and release low virus titers after infection.

Methods

We established a novel in vivo long-term replication model using xenografts of Calu-3 human lung cancer cells in immunodeficient mice. Virus replication in the tumor was monitored for 30 days and occurrence of mutations in the viral genome was determined by whole-genome deep sequencing. Viral isolates with mutations were selected after plaque forming assays and their properties were determined in cells and in K18-hACE2 mice.

Results

After infection with parental SARS-CoV-2, viruses were found in the tumor tissues for up to 30 days and acquired various mutations, predominantly in the spike (S) protein, some of which increased while others fluctuated for 30 days. Three viral isolates with different combination of mutations produced higher virus titers than the parental virus in Calu-3 cells without cytopathic effects. In K18-hACE2 mice, the variants were less lethal than the parental virus. Infection with each variant induced production of cross-reactive antibodies to the receptor binding domain of parental SARS-CoV-2 S protein and provided protective immunity against subsequent challenge with parental virus.

Discussion

These results suggest that most of the SARS-CoV-2 variants acquired mutations promoting host adaptation in the Calu-3 xenograft mice. This model can be used in the future to further study SARS-CoV-2 variants upon long-term replication in vivo .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Spike Glycoprotein, CoronavirusAnimalsHumansMiceCOVID-19Lung NeoplasmsCell Line, Tumor

Stichwörter der Autor:innen

COVID-19K18-hACE2 mouseSARS-CoV-2long-term replication modelvariants

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Autor:innen und Institutionen

  • Institute of Medical Science, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Department of Microbiology, College of Medicine, Hallym University, Chuncheon, Republic of Korea.
  • Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, Republic of Korea.
  • Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju, Republic of Korea.

Förderung

  • National Research Foundation of Korea
  • Korea Health Industry Development Institute

Zitieren

APA

Kim, D., Kim, J., Kim, M., Park, H., Park, S., Maharjan, S., Baek, K., Kang, B. M., Kim, S., Park, M. S., Lee, Y., & Kwon, H. J. (2023). Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2023.1280686

Vancouver

Kim D, Kim J, Kim M, Park H, Park S, Maharjan S, et al. Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2. Frontiers in Cellular and Infection Microbiology. 2023. doi:10.3389/fcimb.2023.1280686

BibTeX
@article{Kim2023,
  author = {Kim, Dongbum and Kim, Jinsoo and Kim, Minyoung and Park, Heedo and Park, Sangkyu and Maharjan, Sony and Baek, Kyeongbin and Kang, Bo Min and Kim, Suyeon and Park, Man-Seong and Lee, Younghee and Kwon, Hyung-Joo},
  title = {Analysis of spike protein variants evolved in a novel in vivo long-term replication model for SARS-CoV-2},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2023},
  doi = {10.3389/fcimb.2023.1280686}
}
Kostenlos starten →